Daily Archives:
July 17th, 2017


  1. Digestive Care Announces FDA Approval of Medication to Treat Pancreatic Insufficiency Due to Cystic Fibrosis

    Digestive Care, Inc. (DCI) and its marketing partner to support the U.S. cystic fibrosis community, Chiesi, today announced U.S. Food and Drug Administration (FDA) approval of PERTZYE® (pancrelipase) in a 24,000 USP lipase units capsule. The newly available dosing strength may allow for consumption of fewer capsules to reach the needed weight-based dose. More: http://mwne.ws/2tyAapF